Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada.
Mov Disord. 2010 Oct 30;25(14):2304-10. doi: 10.1002/mds.23347.
More than 50% of persons with idiopathic REM sleep behavior disorder (RBD) will develop Parkinson's disease or Lewy body dementia. Symptom screens and metaiodobenzylguanine (MIBG)-scintigraphy suggest autonomic abnormalities in idiopathic RBD, but it is unclear whether autonomic abnormalities can predict neurodegenerative disease. From a cohort of 99 patients with idiopathic RBD, we selected those who developed parkinsonism or dementia. These were matched by age, sex, and follow-up duration to patients with RBD who remained disease free and to matched controls. From the polysomnographic trace performed at baseline evaluation, measures of beat-to-beat RR variability including time domains (mean RR-interval and RR-standard deviation) and frequency domains (low and high frequency components) were retrospectively assessed. Twenty-one patients with idiopathic RBD who developed neurodegenerative disease were included (Parkinson's disease-11, multiple system atrophy-1, and dementia-9). Age at PSG was 66 years, and 86% were male. PSG was performed on average 6.7 years before defined neurodegenerative disease. Comparing all patients with idiopathic RBD to controls, there were significant reductions in RR-standard deviation (24.6 ± 2.2 ms vs. 35.2 ± 3.5 ms, P = 0.006), very low frequency components (238.6 ± 99.6 ms(2) vs. 840.1 ± 188.3 ms(2), P < 0.001), and low frequency components (127.8 ± 26.3 ms(2) vs. 288.7 ± 66.2 ms(2), P = 0.032). However, despite clear differences between patients with idiopathic RBD and controls, there were no differences in any measure between those who did or did not develop disease. RR-variability analysis demonstrates substantial autonomic dysfunction in idiopathic RBD. However, this dysfunction is identical in patients who will or will not develop defined neurodegenerative disease. This suggests that autonomic dysfunction is linked with RBD independent of associated Parkinson's disease or Lewy body dementia.
超过 50%的特发性 REM 睡眠行为障碍(RBD)患者会发展为帕金森病或路易体痴呆。症状筛查和间碘苄胍(MIBG)闪烁显像提示特发性 RBD 存在自主神经异常,但自主神经异常是否可以预测神经退行性疾病尚不清楚。我们从一组 99 例特发性 RBD 患者中选择了那些出现帕金森病或痴呆的患者。这些患者按年龄、性别和随访时间与未患 RBD 的患者和匹配的对照组进行匹配。从基线评估时的多导睡眠图记录中,回顾性评估了逐搏 RR 变异性的测量值,包括时域(平均 RR 间隔和 RR 标准差)和频域(低频和高频成分)。共有 21 例特发性 RBD 患者发展为神经退行性疾病(帕金森病 11 例,多系统萎缩 1 例,痴呆 9 例)。PSG 时的年龄为 66 岁,86%为男性。PSG 平均在定义为神经退行性疾病前 6.7 年进行。将所有特发性 RBD 患者与对照组进行比较,RR 标准差(24.6 ± 2.2 ms 与 35.2 ± 3.5 ms,P = 0.006)、极低频成分(238.6 ± 99.6 ms(2) 与 840.1 ± 188.3 ms(2),P < 0.001)和低频成分(127.8 ± 26.3 ms(2) 与 288.7 ± 66.2 ms(2),P = 0.032)均显著降低。然而,尽管特发性 RBD 患者与对照组之间存在明显差异,但在是否发生疾病的患者之间,任何测量值均无差异。RR 变异性分析显示特发性 RBD 存在明显的自主神经功能障碍。然而,这种功能障碍在将要或不会发展为明确的神经退行性疾病的患者中是相同的。这表明自主神经功能障碍与 RBD 相关,而与帕金森病或路易体痴呆无关。